Molina Healthcare, Inc. (MOH) shareholders
Close on Nov 17, 2026Market cap $11.55BP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 4,805,370 | 9.20% | 13G (passive) amendment | Sep 30, 2026 |
| AQR Capital Management Holdings, LLC Joint filing with AQR Capital Management, LLC (6.83%) | 3,560,601 | 6.83% | 13G (passive) amendment | Jun 30, 2026 |
| Abigail P. Johnson Joint filing with FMR LLC (5.80%) | 2,969,388 | 5.80% | 13G (passive) | Dec 31, 2025 |
| AQR Capital Management, LLC Joint filing with AQR Capital Management Holdings, LLC (5.50%) | 2,863,393 | 5.50% | 13G (passive) | Mar 31, 2026 |
| Giovanni Agnelli B.V. Joint filing with Exor N.V. (5.21%), Lingotto Investment Management (UK) Limited (5.21%) and 1 more | 2,718,348 | 5.21% | 13G (passive) | Aug 28, 2026 |
| Vanguard Capital Management | 2,704,951 | 5.19% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of MOH | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 6,572,156 | 12.59% | $1.50B | +203,130 | 0.02% |
| Aqr Capital Management LLC | 3,560,601 | 6.82% | $806.90M | +697,208 | 0.28% |
| Vanguard Portfolio Management LLC | 2,790,243 | 5.35% | $638.13M | −728 | 0.03% |
| Capital World Investors | 2,562,913 | 4.91% | $586.14M | −636,433 | 0.07% |
| Lingotto Investment Management LLP | 2,511,490 | 4.81% | $574.38M | New | 12.31% |
| Vanguard Capital Management LLC | 2,355,261 | 4.51% | $538.65M | +45,031 | 0.01% |
| Victory Capital Management Inc | 1,980,615 | 3.79% | $452.97M | −90,084 | 0.25% |
| FMR LLC | 1,871,290 | 3.58% | $427.96M | −1,333,634 | 0.02% |
| State Street Corp | 1,755,467 | 3.36% | $401.48M | +25,026 | 0.01% |
| Dimensional Fund Advisors LP | 1,393,338 | 2.67% | $318.66M | −1,544 | 0.06% |
| Goldman Sachs Group Inc | 1,306,563 | 2.50% | $298.81M | +579,678 | 0.03% |
| Wellington Management Group Llp | 1,267,207 | 2.43% | $289.81M | +135,247 | 0.05% |
| Two Sigma Investments, LP | 1,266,338 | 2.43% | $289.61M | −84,357 | 0.21% |
| Price T Rowe Associates Inc /Md/ | 1,248,757 | 2.39% | $285.59M | +267,008 | 0.03% |
| Capital Research Global Investors | 1,092,251 | 2.09% | $249.80M | +4,446 | 0.03% |
| Morgan Stanley | 1,007,068 | 1.93% | $230.32M | +1,071 | 0.01% |
| Harris Associates L P | 957,500 | 1.83% | $218.98M | −20,647 | 0.29% |
| Geode Capital Management, LLC | 891,772 | 1.71% | $204.01M | −29,241 | 0.01% |
| Manning & Napier Advisors LLC | 663,669 | 1.27% | $152.34M | +118,252 | 1.95% |
| Baupost Group LLC/Ma | 633,609 | 1.21% | $144.91M | – | 2.68% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 600 | 56M | 100.0% | 155 / 212 | 173 / 75 | 10M | 9M |
| Q1 2026 | 527 | 55M | 100.0% | 132 / 194 | 168 / 145 | 21M | 13M |
| Q4 2025 | 552 | 54M | 100.0% | 108 / 169 | 239 / 170 | 13M | 15M |
| Q3 2025 | 626 | 57M | 100.0% | 132 / 257 | 192 / 124 | 13M | 10M |
| Q2 2025 | 626 | 53M | 100.0% | 92 / 241 | 238 / 76 | 4M | 4M |
| Q1 2025 | 619 | 54M | 100.0% | 85 / 208 | 244 / 89 | 5M | 4M |
| Q4 2024 | 634 | 53M | 100.0% | 100 / 230 | 237 / 73 | 4M | 7M |
| Q3 2024 | 618 | 56M | 100.0% | 68 / 223 | 254 / 88 | 8M | 6M |
| Q2 2024 | 642 | 60M | 100.0% | 106 / 257 | 202 / 80 | 6M | 5M |
| Q1 2024 | 627 | 59M | 100.0% | 80 / 240 | 216 / 56 | 4M | 3M |
| Q4 2023 | 610 | 59M | 100.0% | 107 / 223 | 208 / 51 | 4M | 3M |
| Q3 2023 | 564 | 59M | 100.0% | 71 / 202 | 218 / 55 | 4M | 4M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
425 funds held MOH in Q2 2026, 48% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of MOH | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 3,137,793 | 6.01% | $717.61M | 0.64% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 1,654,954 | 3.17% | $378.49M | 0.02% | Jun 30, 2026 |
| Victory Sycamore Established Value Fund | 1,435,000 | 2.75% | $328.18M | 2.13% | Jun 30, 2026 |
| SMALLCAP World Fund Inc | 1,326,392 | 2.54% | $303.35M | 0.32% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 1,194,366 | 2.29% | $273.15M | 0.14% | Jun 30, 2026 |
| Capital World Growth & Income Fund | 794,486 | 1.52% | $137.92M | 0.09% | May 31, 2026 |
| Vanguard Small-Cap Value Index Fund | 756,896 | 1.45% | $173.10M | 0.26% | Jun 30, 2026 |
| American Balanced Fund | 714,702 | 1.37% | $163.45M | 0.06% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 597,577 | 1.14% | $136.67M | 0.14% | Jun 30, 2026 |
| T. Rowe Price Mid-Cap Value Fund, Inc. | 588,167 | 1.13% | $134.51M | 0.82% | Jun 30, 2026 |
| Vanguard Global Capital Cycles Fund | 485,957 | 0.93% | $95.06M | 2.54% | Jul 31, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF | 477,955 | 0.92% | $109.31M | 0.65% | Jun 30, 2026 |
| iShares S&P Small-Cap 600 Value ETF | 448,496 | 0.86% | $102.57M | 1.28% | Jun 30, 2026 |
| Invesco S&P SmallCap 600 Revenue ETF | 344,355 | 0.66% | $59.78M | 3.20% | May 31, 2026 |
| Vanguard Tax-Managed Small-Cap Fund | 316,112 | 0.61% | $72.29M | 0.63% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Joseph M. Zubretsky | President & CEO, Director | 646,663 | 1.24% | Nov 13, 2026 |
| Jeff D. Barlow | Chief Legal Officer | 59,313 | 0.11% | Nov 13, 2026 |
| Debra Bacon | EVP, Medicaid | 21,636 | 0.04% | Jul 2, 2026 |
| James Woys | Chief Operating Officer | 90,178 | 0.17% | Jul 2, 2026 |
| Maurice Hebert | Chief Accounting Officer | 12,815 | 0.02% | May 15, 2026 |
| Mark Lowell Keim | Chief Financial Officer | 83,251 | 0.16% | Mar 2, 2026 |
| Steven J. Orlando | Director | 63,319 | 0.12% | Nov 16, 2026 |
| Dale B. Wolf | Director | 30,046 | 0.06% | Nov 13, 2026 |
| Richard M. Schapiro | Director | 11,833 | 0.02% | Nov 13, 2026 |
| Francis S. Soistman Jr | Director | 1,211 | 0.00% | Oct 2, 2026 |
| Barbara L. Brasier | Director | 6,122 | 0.01% | Oct 2, 2026 |
| Stephen H. Lockhart | Director | 4,688 | 0.01% | Oct 2, 2026 |
| Ronna Romney | Director | 44,382 | 0.09% | Oct 2, 2026 |
| Leo P. Grohowski | Director | 1,846 | 0.00% | Oct 2, 2026 |
| Richard C. Zoretic | Director | 9,693 | 0.02% | Oct 2, 2026 |
| Daniel Cooperman | Director | 14,929 | 0.03% | Apr 2, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Steven J. Orlando Director | Nov 16, 2026 | Sale | −702 | $227.33 | $159.59K | 17,569 |
| Dale B. Wolf Director | Nov 13, 2026 | Sale | −1,600 | $206.12 | $329.79K | 14,337 |
| Joseph M. Zubretsky President & CEO, Director | Nov 13, 2026 | Gift | −6,500 | – | – | 279,976 |
| Jeff D. Barlow Chief Legal Officer | Nov 10, 2026 | Sale | −8,000 | $203.07 | $1.62M | 59,313 |
| Richard M. Schapiro Director | Nov 10, 2026 | Sale | −782 | $203.94 | $159.48K | 11,833 |
| Stephen H. Lockhart Director | Oct 1, 2026 | Award | +304 | $180.85 | $54.98K | 4,688 |
| Richard M. Schapiro Director | Oct 1, 2026 | Award | +304 | $180.85 | $54.98K | 12,615 |
| Richard C. Zoretic Director | Oct 1, 2026 | Award | +304 | $180.85 | $54.98K | 9,693 |
| Leo P. Grohowski Director | Oct 1, 2026 | Award | +304 | $180.85 | $54.98K | 1,846 |
| Francis S. Soistman Jr Director | Oct 1, 2026 | Award | +304 | $180.85 | $54.98K | 1,211 |
| Dale B. Wolf Director | Oct 1, 2026 | Award | +304 | $180.85 | $54.98K | 15,937 |
| Steven J. Orlando Director | Oct 1, 2026 | Award | +304 | $180.85 | $54.98K | 18,271 |
| Ronna Romney Director | Oct 1, 2026 | Award | +304 | $180.85 | $54.98K | 18,173 |
| Barbara L. Brasier Director | Oct 1, 2026 | Award | +304 | $180.85 | $54.98K | 6,122 |
| Stephen H. Lockhart Director | Jul 1, 2026 | Award | +237 | $232.55 | $55.11K | 4,384 |
| Ronna Romney Director | Jul 1, 2026 | Award | +237 | $232.55 | $55.11K | 17,869 |
| Barbara L. Brasier Director | Jul 1, 2026 | Award | +237 | $232.55 | $55.11K | 5,818 |
| Richard M. Schapiro Director | Jul 1, 2026 | Award | +237 | $232.55 | $55.11K | 12,311 |
| Steven J. Orlando Director | Jul 1, 2026 | Award | +237 | $232.55 | $55.11K | 17,967 |
| Dale B. Wolf Director | Jul 1, 2026 | Award | +237 | $232.55 | $55.11K | 15,633 |
| Francis S. Soistman Jr Director | Jul 1, 2026 | Award | +237 | $232.55 | $55.11K | 907 |
| Leo P. Grohowski Director | Jul 1, 2026 | Award | +237 | $232.55 | $55.11K | 1,542 |
| Debra Bacon EVP, Medicaid | Jul 1, 2026 | Tax withholding | −183 | $232.55 | $42.56K | 21,636 |
| Richard C. Zoretic Director | Jul 1, 2026 | Award | +237 | $232.55 | $55.11K | 9,389 |
| James Woys Chief Operating Officer | Jun 30, 2026 | Award | +144 | $147.51 | $21.24K | 90,178 |
| Jeff D. Barlow Chief Legal Officer | Jun 30, 2026 | Award | +138 | $147.51 | $20.36K | 67,313 |
| Debra Bacon EVP, Medicaid | Jun 30, 2026 | Award | +23 | $147.51 | $3.39K | 21,819 |
| Maurice Hebert Chief Accounting Officer | May 14, 2026 | Sale | −600 | $191.55 | $114.93K | 12,815 |
| Jeff D. Barlow Chief Legal Officer | May 11, 2026 | Sale | −17,811 | $186.12 | $3.31M | 67,175 |
| Francis S. Soistman Jr Director | May 6, 2026 | Award | +170 | $197.44 | $33.56K | 670 |
| Barbara L. Brasier Director | Apr 1, 2026 | Award | +405 | $135.82 | $55.01K | 5,581 |
| Stephen H. Lockhart Director | Apr 1, 2026 | Award | +405 | $135.82 | $55.01K | 4,147 |
| Ronna Romney Director | Apr 1, 2026 | Award | +405 | $135.82 | $55.01K | 17,632 |
| Leo P. Grohowski Director | Apr 1, 2026 | Award | +405 | $135.82 | $55.01K | 1,305 |
| Richard C. Zoretic Director | Apr 1, 2026 | Award | +405 | $135.82 | $55.01K | 9,152 |
| Dale B. Wolf Director | Apr 1, 2026 | Award | +405 | $135.82 | $55.01K | 15,396 |
| Richard M. Schapiro Director | Apr 1, 2026 | Award | +405 | $135.82 | $55.01K | 12,074 |
| Steven J. Orlando Director | Apr 1, 2026 | Award | +405 | $135.82 | $55.01K | 17,730 |
| Ronna Romney Director | Mar 12, 2026 | Sale | −506 | $146.92 | $74.34K | 17,227 |
| Jeff D. Barlow Chief Legal Officer | Mar 1, 2026 | Tax withholding | −1,638 | $154.05 | $252.33K | 71,264 |
| Jeff D. Barlow Chief Legal Officer | Mar 1, 2026 | Award | +13,722 | $145.75 | $2.00M | 84,986 |
| Maurice Hebert Chief Accounting Officer | Mar 1, 2026 | Award | +650 | $154.05 | $100.13K | 11,858 |
| Maurice Hebert Chief Accounting Officer | Mar 1, 2026 | Award | +2,058 | $145.75 | $299.95K | 13,415 |
| Maurice Hebert Chief Accounting Officer | Mar 1, 2026 | Tax withholding | −229 | $154.05 | $35.28K | 11,629 |
| Maurice Hebert Chief Accounting Officer | Mar 1, 2026 | Tax withholding | −272 | $154.05 | $41.90K | 11,357 |
| Mark Lowell Keim Chief Financial Officer | Mar 1, 2026 | Award | +26,073 | $145.75 | $3.80M | 83,251 |
| Mark Lowell Keim Chief Financial Officer | Mar 1, 2026 | Tax withholding | −2,308 | $154.05 | $355.55K | 57,178 |
| James Woys Chief Operating Officer | Mar 1, 2026 | Tax withholding | −1,313 | $154.05 | $202.27K | 73,018 |
| James Woys Chief Operating Officer | Mar 1, 2026 | Award | +17,016 | $145.75 | $2.48M | 90,034 |
| Joseph M. Zubretsky President & CEO, Director | Mar 1, 2026 | Award | +66,417 | $145.75 | $9.68M | 99,015 |
| Joseph M. Zubretsky President & CEO, Director | Mar 1, 2026 | Tax withholding | −8,597 | $154.05 | $1.32M | 32,598 |
| Debra Bacon EVP, Medicaid | Mar 1, 2026 | Tax withholding | −716 | $154.05 | $110.30K | 12,190 |
| Debra Bacon EVP, Medicaid | Mar 1, 2026 | Award | +9,606 | $145.75 | $1.40M | 21,796 |
| Richard C. Zoretic Director | Feb 11, 2026 | Buy | +800 | $125.16 | $100.13K | 8,747 |
| Dale B. Wolf Director | Jan 1, 2026 | Award | +317 | $173.54 | $55.01K | 14,991 |
| Leo P. Grohowski Director | Jan 1, 2026 | Award | +317 | $173.54 | $55.01K | 900 |
| Barbara L. Brasier Director | Jan 1, 2026 | Award | +317 | $173.54 | $55.01K | 5,176 |
| Richard M. Schapiro Director | Jan 1, 2026 | Award | +317 | $173.54 | $55.01K | 11,669 |
| Stephen H. Lockhart Director | Jan 1, 2026 | Award | +317 | $173.54 | $55.01K | 3,742 |
| Richard C. Zoretic Director | Jan 1, 2026 | Award | +317 | $173.54 | $55.01K | 7,947 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Molina Healthcare's stock actually held short. Settlement fails (shares not delivered on time) peaked at 386 shares on Sep 24, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Jeff D. Barlow Officer | Nov 10, 2026 | 8,000 | $1.62M | Nov 10, 2026 | Performance Shares |
| Richard Shapiro Director | Nov 10, 2026 | 782 | $159.02K | Nov 10, 2026 | Grants for director rule 16b-3 |
| Maurice Hebert Officer | May 14, 2026 | 600 | $114.93K | May 14, 2026 | Performance Shares |
| Jeff D. Barlow Officer | May 11, 2026 | 17,811 | $3.31M | May 11, 2026 | Restricted Stock |
| Ronna Romney Director | Mar 12, 2026 | 506 | $74.22K | Mar 11, 2026 | Stock Award |
| Richard M. Schapiro Director | Nov 24, 2025 | 357 | $50.54K | Nov 24, 2025 | Grant Awards |
| Ronna Romney Director | Aug 4, 2025 | 700 | $110.59K | Aug 4, 2025 | Stock Award |
| The Dale B. Wolf Revocable Trust Director | May 21, 2025 | 1,500 | $484.32K | May 21, 2025 | Exercise of options under a registered plan |
| Steven J. Orlando Director | May 2, 2025 | 1,000 | $315.00K | May 5, 2025 | Grants for Director rule 16b-3 |
| Joseph M. Zubretsky President / CEO / Director | Apr 30, 2025 | 87,500 | $27.98M | Apr 30, 2025 | RSU Vesting |
| Richard M. Schapiro Director | Apr 29, 2025 | 669 | $214.21K | Apr 29, 2025 | Compensation |
| Steven J. Orlando Director | Mar 3, 2025 | 1,000 | $301.00K | Mar 3, 2025 | Board Compensation |
| Richard M. Schapiro Director | Oct 28, 2024 | 136 | $44.27K | Oct 28, 2024 | Compensation |
| Steven J. Orlando Director | Oct 28, 2024 | 750 | $243.75K | Oct 29, 2024 | Grants for director rule 16b-3 |
| Maurice Hebert Officer | Aug 15, 2024 | 393 | $136.18K | Aug 15, 2024 | PERFORMANCE SHARES |
Congress trades
11 trades in Molina Healthcare reported by 5 members of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Gilbert Cisneros CA31 | Sold (part) | Nov 12, 2025 | $1K–15K | Dec 15, 2025 |
| Byron Donalds FL19 | Sold | Sep 4, 2025 | $1K–15K | Oct 7, 2025 |
| Byron Donalds FL19 · spouse | Sold | Sep 4, 2025 | $1K–15K | Oct 7, 2025 |
| Gilbert Cisneros CA31 | Bought | Aug 5, 2025 | $1K–15K | Sep 12, 2025 |
| Gilbert Cisneros CA31 | Sold (part) | May 30, 2025 | $1K–15K | Jun 6, 2025 |
| Rob Bresnahan PA08 | Bought | May 15, 2025 | $1K–15K | Jun 9, 2025 |
| Gilbert Cisneros CA31 | Bought | Apr 29, 2025 | $1K–15K | May 6, 2025 |
| Rob Bresnahan PA08 · joint account | Sold | Jan 13, 2025 | $1K–15K | Feb 13, 2025 |
| Daniel Goldman NY10 | Sold | Jul 12, 2023 | $15K–50K | Aug 13, 2023 |
| Earl Blumenauer OR03 · spouse | Bought | Jun 15, 2023 | $15K–50K | Jul 12, 2023 |
| Daniel Goldman NY10 | Bought | Apr 10, 2023 | $15K–50K | May 19, 2023 |
See a number that looks wrong?